Serial Number
98910046
Owner
NEURODISCOVERY AI, INC.Attorney
Paul MartelloFirst Use Date
Aug 1, 2024
Filing Date
Dec 18, 2024
NEURODISCOVERY AI Trademark
Serial Number: 98910046 • Registration: 8347355
Trademark Classes
Owner Contact Info
4080 McGinnis Ferry Rd Bldg 1400, STE 1404
Alpharetta, GA 30005
Entity Type: 03
Legal Representation
Correspondence Address
Paul Martello LZ Legal Services, LLC
2828 N Central Ave, PMB #1510
Phoenix, AZ 85004
United States
Trademark Details
Filing Date
December 18, 2024
Registration Date
July 14, 2026
First Use Anywhere
August 1, 2024
First Use in Commerce
August 1, 2024
Published for Opposition
July 8, 2025
Goods & Services
Biotechnology research; Drug discovery services; Medical research; Platform as a service (PAAS) featuring computer software platforms for data licensing, analyzing patient medical records and analyzing healthcare data to provide insights on medical treatment effectiveness and safety, enrolling patients in clinical trials, identifying prospective patients for clinical trials, optimizing workflows and databases for medical service providers, and detecting and monitoring biomarkers related to neurological diseases and disorders; Scientific research; Scientific research consulting in the field of clinical trials and neurology; Software as a service (SAAS) services featuring software for data licensing, analyzing patient medical records and analyzing healthcare data to provide insights on medical treatment effectiveness and safety, enrolling patients in clinical trials, identifying prospective patients for clinical trials, optimizing workflows and databases for medical service providers, and detecting and monitoring biomarkers related to neurological diseases and disorders
Business consulting and management in the field of clinical trials, namely, management and compilation of computerized databases in the field of clinical trials for business purposes; Recruitment advertisement services, namely, posting of clinical trial notices for the purpose of recruiting patients for participation in clinical trials for the testing of drugs